57 related articles for article (PubMed ID: 31022310)
1. Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies.
Kobie J; Guo Z; Cho CR; Menzel K; McCrea JB; Blanchard R; Shaw PM
J Clin Pharmacol; 2019 Sep; 59(9):1236-1243. PubMed ID: 31022310
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the inhibitory effects of itraconazole on letermovir.
McCrea JB; Menzel K; Fancourt C; Witter R; Zhao T; Robbins JA; Stoch SA; Iwamoto M
Br J Clin Pharmacol; 2023 Jul; 89(7):2122-2130. PubMed ID: 36717270
[TBL] [Abstract][Full Text] [Related]
3. The frequency of major
Alrajeh K; AlAzzeh O; Roman Y
Pharmacogenomics; 2023 May; 24(7):381-398. PubMed ID: 37222158
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP.
Mykkänen AJH; Tarkiainen EK; Taskinen S; Neuvonen M; Paile-Hyvärinen M; Lilius TO; Tapaninen T; Klein K; Schwab M; Backman JT; Tornio A; Niemi M
Clin Pharmacol Ther; 2024 Jun; 115(6):1428-1440. PubMed ID: 38493369
[TBL] [Abstract][Full Text] [Related]
5. Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study.
Borić-Bilušić AA; Božina N; Lalić Z; Lovrić M; Nađ-Škegro S; Penezić L; Barišić K; Trkulja V
Adv Ther; 2023 Feb; 40(2):601-618. PubMed ID: 36434147
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients.
Groll AH; Schulte JH; Antmen AB; Fraser CJ; Teal VL; Haber B; Caro L; McCrea JB; Fancourt C; Patel M; Menzel K; Badshah C
Pediatr Infect Dis J; 2024 Mar; 43(3):203-208. PubMed ID: 38241643
[TBL] [Abstract][Full Text] [Related]
7. Impact of Genetic Variants in ABCG2 , NR1I2 , and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children.
Spector SA; Brummel SS; Chang A; Wiznia A; Ruel TD; Acosta EP;
J Acquir Immune Defic Syndr; 2024 Mar; 95(3):297-303. PubMed ID: 38180896
[TBL] [Abstract][Full Text] [Related]
8. Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population.
Fan J; He HY; Li HH; Wu PL; Tang L; Deng BY; Dong WH; Wang JH
BMC Pediatr; 2024 Jan; 24(1):82. PubMed ID: 38279097
[TBL] [Abstract][Full Text] [Related]
9. Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban.
Han JM; Jang EJ; Yee J; Song TJ; Kim DH; Park J; Gwak HS
Sci Rep; 2023 Sep; 13(1):15967. PubMed ID: 37749323
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic variants affecting efficacy and toxicity of statins in a south Asian population from Sri Lanka.
Ranasinghe P; Sirisena N; Ariadurai JN; Vishnukanthan T; Thilakarathne S; Anandagoda G; Dissanayake VH
Pharmacogenomics; 2023 Oct; 24(15):809-819. PubMed ID: 37877238
[No Abstract] [Full Text] [Related]
11. Large-scale next generation sequencing based analysis of SLCO1B1 pharmacogenetics variants in the Saudi population.
Goljan E; Abouelhoda M; Tahir A; ElKalioby M; Meyer B; Monies D
Hum Genomics; 2024 Mar; 18(1):30. PubMed ID: 38523294
[TBL] [Abstract][Full Text] [Related]
12. Do Gene Polymorphisms Play a Role in Newborn Hyperbilirubinemia?
Hakan N; Aydin M; Ceylaner S; Dilli D; Zenciroğlu A; Okumuş N
Balkan J Med Genet; 2023 Dec; 26(2):51-58. PubMed ID: 38482260
[TBL] [Abstract][Full Text] [Related]
13. Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver.
van Groen BD; Bi C; Gaedigk R; Staggs VS; Tibboel D; de Wildt SN; Leeder JS
Clin Transl Sci; 2020 May; 13(3):509-519. PubMed ID: 31917523
[TBL] [Abstract][Full Text] [Related]
14. Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.
Alqasrawi MN; Al-Mahayri ZN; Alblooshi H; Alsafar H; Ali BR
Curr Vasc Pharmacol; 2024 Jan; ():e260124226224. PubMed ID: 38284696
[TBL] [Abstract][Full Text] [Related]
15. Revisiting
Emery LP; Brooks GA
JCO Oncol Pract; 2022 Apr; 18(4):281-282. PubMed ID: 35108028
[No Abstract] [Full Text] [Related]
16. Letermovir and new horizons in prevention of post-transplant CMV.
Siegrist EA; Sassine J
Expert Rev Clin Pharmacol; 2023; 16(10):887-889. PubMed ID: 37706302
[No Abstract] [Full Text] [Related]
17. A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent β-thalassemia.
Shrestha O; Khadwal AR; Singhal M; Trehan A; Bansal D; Jain R; Pal A; Hira JK; Chhabra S; Malhotra P; Das R; Sharma P
Ann Hematol; 2020 Sep; 99(9):2019-2026. PubMed ID: 32676731
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients.
Prohn M; Viberg A; Zhang D; Dykstra K; Davis C; Macha S; Sabato P; de Alwis D; Iwamoto M; Fancourt C; Cho CR
CPT Pharmacometrics Syst Pharmacol; 2021 Mar; 10(3):255-267. PubMed ID: 33440077
[TBL] [Abstract][Full Text] [Related]
19. Absorption, Metabolism, Distribution, and Excretion of Letermovir.
Menzel K; Kothare P; McCrea JB; Chu X; Kropeit D
Curr Drug Metab; 2021; 22(10):784-794. PubMed ID: 33622223
[TBL] [Abstract][Full Text] [Related]
20. Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants.
McCrea JB; Menzel K; Adedoyin A; Cho CR; Fox-Bosetti S; Macha S; Zhao T; Liu F; Panebianco D; Stoch SA; Iwamoto M
Clin Pharmacol Drug Dev; 2022 Apr; 11(4):420-428. PubMed ID: 35157785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
